Pharmacy World & Science

, Volume 32, Issue 6, pp 730–736

The Pharmaceutical care of patients with type 2 diabetes mellitus

  • Anna Paula de Sá Borges
  • Camilo Molino Guidoni
  • Lígia Domingues Ferreira
  • Osvaldo de Freitas
  • Leonardo Régis Leira Pereira
Research Article

DOI: 10.1007/s11096-010-9428-3

Cite this article as:
Borges, A.P.S., Guidoni, C.M., Ferreira, L.D. et al. Pharm World Sci (2010) 32: 730. doi:10.1007/s11096-010-9428-3

Abstract

Objective To evaluate the efficiency of pharmaceutical care on the control of clinical parameters, such as fasting glycaemia and glycosylated haemoglobin in patients with Type 2 Diabetes mellitus. Setting This study was conducted at the Training and Community Health Centre of the College of Medicine of Ribeirao Preto, University of Sao Paulo, Brazil. Methods A prospective and experimental study was conducted with 71 participants divided in two groups: (i) pharmaceutical care group (n=40), and (ii) the control group (n=31). The distribution of patients within these groups was made casually, and the patients were monitored for 12 months. Main outcome measure: Values for fasting glycaemia and glycosylated haemoglobin were collected. Results Mean values of fasting glycaemia in the pharmaceutical care group were significantly reduced whilst a small reduction was detected in the control group at the same time. A significant reduction in the levels of glycosylated haemoglobin was detected in patients in the pharmaceutical care group, and an average increase was observed in the control group. Furthermore, the follow-up of the intervention group by a pharmacist contributed to the resolution of 62.7% of 142 drug therapy problems identified. Conclusion In Brazil, the information provided by a pharmacist to patients with Type 2 Diabetes mellitus increases compliance to treatment, solving or reducing the Drug Therapy Problem and, consequently, improving glycaemic control.

Keywords

BrazilBrazilian Public Health SystemComplianceFasting glycaemiaGlycosylated haemoglobinPharmacistPharmaceutical CareType 2 Diabetes mellitus

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Anna Paula de Sá Borges
    • 1
  • Camilo Molino Guidoni
    • 1
  • Lígia Domingues Ferreira
    • 1
  • Osvaldo de Freitas
    • 1
  • Leonardo Régis Leira Pereira
    • 1
  1. 1.Department of Pharmaceutical Sciences, College of Pharmaceutical Science of Ribeirao PretoUniversity of Sao Paulo - USPRibeirao PretoBrazil